Daniel G. Barrus

MedicineNeurosciencePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018”.

In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018

Pharmacology Biochemistry and Behavior(2020)10.1016/j.pbb.2020.172918

N/A

0DataRank · unranked

17 citations

Daniel G. Barrus, Richard C. Kevin, David B. Finlay, Timothy W. Lefever, Purvi R. Patel +6 more

The Role of Brain Interleukin-1 in Stress-Enhanced Fear Learning

UNC Libraries(2020)10.17615/4f4j-q570

N/A

0DataRank · unranked

0 citations

Christina L. Lebonville, Meghan Jones, Daniel G. Barrus, Donald T. Lysle

Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids

Bioorganic & Medicinal Chemistry(2021)10.1016/j.bmc.2021.116215

N/A

0DataRank · unranked

16 citations

Thomas F. Gamage, Ann M. Decker, David B. Finlay, Tiffany L. Langston, Daniel G. Barrus +4 more

Axially Chiral Cannabinoids: Design, Synthesis, and Cannabinoid Receptor Affinity

Journal of the American Chemical Society(2023)10.1021/jacs.3c00129

N/A

0DataRank · unranked

21 citations

Anghelo J. Gangano, Daniel G. Barrus, Kyle J. Rehrauer, Terry-Elinor Reid, Primali V. Navaratne +7 more

Axially Chiral Cannabinoids: Design, Synthesis, and Cannabinoid Receptor Affinity

ChemRxiv(2023)10.26434/chemrxiv-2023-k24c1

N/A

0DataRank · unranked

0 citations

Anghelo J. Gangano, Primali V. Navaratne, Daniel G. Barrus, Kyle J. Rehrauer, Terry-Elinor Reid +6 more

Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry(2024)10.1016/j.pnpbp.2024.110984

N/A

0DataRank · unranked

5 citations

Julie A. Marusich, Bruce E. Blough, Ojas A. Namjoshi, Marcus F. Brackeen, Luli R. Akinfiresoye +5 more

Development of Diphenyl-1,2,4-Oxadiazole Analogues as Allosteric Modulators of the RXFP3 Receptor: Evaluation of Importance of the N-Substituted-2-Pyrrolidone Moiety in RLX-33

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c00361

N/A

0DataRank · unranked

2 citations

Hetti Handi Chaminda Lakmal, Brooke N. Bender, Md Toufiqur Rahman, Elaine A. Gay, Daniel G. Barrus +5 more